Sunitinib appears to be an effective single-agent therapy for patients with recurrent non-small-cell lung cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1626, 2008-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib may be an effective therapy for elderly patients with advanced non-small-cell lung cancer

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

PEG filgrastim [SD-01] appears to have `therapeutic advantages' over filgrastim in patients receiving chemotherapy for non-small-cell lung cancer

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Gefitinib is an effective treatment for patients with non-small-cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Combination therapy versus single agent chemotherapy in non-small cell lung cancer

By Cheong Kerry Spicer James Chowdhury Simon Harper Peter

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 10, 2005-08 ,pp. : 1693-1700

Informa Healthcare

Access to resources Recommend Favorite

Tegafur/uracil in combination with cisplatin appears to be active in advanced non-small-cell lung cancer

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite